No Data
No Data
Press Release: RAPT Therapeutics Deepens Expertise in Allergic Diseases With Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
RAPT Therapeutics Deepens Expertise in Allergic Diseases With Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
We're Not Very Worried About RAPT Therapeutics' (NASDAQ:RAPT) Cash Burn Rate
Analysts Conflicted on These Healthcare Names: Mind Medicine (MNMD), RAPT Therapeutics (RAPT) and LifeMD (LFMD)
RAPT Therapeutics Analyst Ratings
H.C. Wainwright Maintains RAPT Therapeutics(RAPT.US) With Buy Rating, Maintains Target Price $10